Latest from Healthcare

Sector surge: August Equity expects the dementia market to grow considerably

August Equity closes second deal from its new fund by investing in dementia care market

Specialist investor August Equity has made a new acquisition from its Partners III fund and added a social care business to its portfolio.

Healthcare IT: Civic's software is for the clinical trials market

Albion Ventures makes another healthcare IT play through SaaS firm Cisiv

US-based investor Albion Ventures has expanded its SaaS portfolio by backing healthcare offering Cisiv.

MedPlast is hoping to grow its customer base and global strategic footprint

UK acquisition for US private equity firm Baird Capital

Baird Capital portfolio company MedPlast has snapped up UK-based Orthoplastics for an undisclosed amount.

Aridhia combines information technology, health informatics and analytics

From digital marketing to biomedical informatics in a week for Scottish Equity Partners

Scottish Equity Partners has closed its second deal in a week by investing in Aridhia Informatics alongside fellow VC Albion Ventures.

Healthcare market: The surgery tool has achieved good early traction

Angel CoFund backs surgery tool for the second time to help with world growth

A new technology aimed improving the speed of surgical procedures has closed the first stage of a £2.5 million funding round.

Quality of life: Acacia Pharma is developing products aimed at supportive care

British medical company Acacia Pharma secures £15 million funding

A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.

New approach: There is no need for fridges or freezers with Biofortuna technology

Biofortuna secures more venture capital cash to ramp up US efforts

Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.

High street: Chemists in the UK are growing revenues by adding new products

Private equity looks to pharmacy market for solid returns through consolidation

The steady income streams and low risk profiles of pharmacy businesses are proving increasingly attractive for private equity investors, new figures suggest.

Practice Plan will be adding to Wesleyan Assurance Society's dental offering

Practice Plan finds new home with trade buyer after Dunedin Private Equity exit

An eight-year involvement with dental membership plan business Practice Plan has netted Dunedin Private Equity a 2.8x return on its investment.

Olympian: Sir Chris Hoy is an official brand ambassador for Sport in Science

Sports nutrition business used by Sir Chris Hoy joins London's junior exchange

Science in Sport is targeting its share of a reported £19.6 billion global market in 2010 by securing a stock market listing.

Willowbrook Healthcare now employs 938 staff and has 13 freehold homes

Graphite Capital closes third healthcare exit with same management team

Private equity firm Graphite Capital has followed up on its recent investment in the Hawksmoor chain of restaurants by exiting its interest in Willowbrook Healthcare.

The Biomedical Catalyst was designed to target the 'valley of death' funding gap

Spending review outlines raft of new healthcare sector business investments

The Biomedical Catalyst is allocating £25.9 million as part of a new support package for businesses and academic projects in the health industry.

Clinical research: The inventor of the SnapFast£ system, Ryan Cawood

'Lego for DNA' biotech start-up secures £150,000 of SEIS capital from Mercia

The Seed Enterprise Investment Scheme (SEIS) has allowed biotechnology business Oxford Genetics to net £150,000 of new funding.

Biomedical market: Absynth is developing vaccines to treat bacterial infections

Spin-out biomedical business gets SPARK Impact-led investment

The North West Fund for Biomedical and Fusion IP are coming together to back the growth ambition of University of Sheffield spin-out Absynth Biologics.

Medical market: Tomorrows Medicines operates in the clinical trials sector

The North West Fund for Biomedical makes 60th investment

A £250,000 investment led North West Fund for Biomedical will be used by Tomorrows Medicines to commercialise its new platform.

Software service: CliniSys produces products for clinical laboratories

ECI Partners sells CliniSys to Montagu Equity Partners to close first exit of 2013

Private equity firm ECI Partners has sold its stake in CliniSys and netted a 2.5x return on its 2007 investment.

Lower costs: ChemistDirect has taken the pharmacy online

Online pharmacy set up in garden shed dials up $10 million Atomico-led investment

Venture capital firm Atomico has stepped up to lead a $10 million investment into ChemistDirect.

Innovation: Imperial invests in tech from four universities, including Cambridge

Imperial Innovations pulls in £30 million from EIB to invest in biotech

AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.

Sitting pretty: Beverly Lawrence was marketing director before becoming MD

NVM Private Equity backs second MBO in a week

A thirty one-year old specialist furniture business has taken on private equity backing as it looks to grow through organic and acquisitive means.

Healthcare work: Perfecus Biomed conducts microbiological testing on bacteria

Perfectus Biomed signs up two venture capital backers for infection treatment development

The £25 million North West Fund for Biomedical has made its 57th investment to date through the backing of Perfectus Biomed.

More from GrowthBusiness

The Entrepreneur

Success is determined by professional and personal factors

Have you ever wondered what secrets make top business leaders so successful?

Here, we look at the little things that add up to form the profile of a successful entrepreneur. 

Growing A Business

Brian Cox at the Rolex Awards for Enterprise

Inside The Rolex Awards for Enterprise

In this video, we look at the awards supporting those with a special spirit of enterprise. 

Comment & Analysis

Achieving greater gender parity in the boardroom has become a strategic imperative for many firms

Feminising modern management

Margaret Kett discusses the issue of gender diversity in the boardroom and what can propel women into the higher echelons of management. 

Research

'28% of organisations do not measure the cost of customer service'

Report exposes lack of ROI insight from customer service

The gap in businesses’ measurement of customer experience means they don’t know what customers really want, research finds